Hovione

What they make

1 input Hovione supplies

Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.

Intelligence

What's known

Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.

• Did you know2024

  Hovione's spray drying technology for pharmaceutical amorphous solid dispersions (ASD) is the same thermodynamic process — atomizing a liquid solution and evaporating solvent in a hot gas stream to produce a powder — used industrially since 1872 to make instant coffee (a spray-dried extract) and powdered milk (whole milk spray-dried for infant formula). The fundamental process physics of Hovione's pharmaceutical spray dryers and Nestlé's instant coffee spray towers are identical; what differs is particle size target, inlet temperature, solvent system, containment grade, and GMP documentation. Hovione's budesonide ASD spray drying and a dairy company's milk powder spray drying share atomizer nozzle designs from the same handful of spray drying equipment manufacturers (APV, GEA, Niro/GEA). During COVID-19, budesonide — Hovione's primary inhalation API — was evaluated in the Oxford PRINCIPLE trial as a treatment for early-stage COVID-19 respiratory symptoms. When the PRINCIPLE trial showed benefit (2021), demand for budesonide prescriptions for COVID treatment briefly competed with the existing supply of budesonide for asthma/COPD maintenance patients, whose conditions continued regardless of the pandemic — a single inhalation API simultaneously serving a chronic disease and an acute pandemic response.

  Hovione ↗

• Origin2024

  Hovione was founded in 1959 in Loures, Portugal by Ivan Villax — a Czech organic chemist who had fled Communist Czechoslovakia after the 1948 coup. Villax escaped to Portugal during the Cold War, where Salazar's Estado Novo regime provided political stability for a Western-oriented chemical business at a time when most of Western Europe was recovering from WWII and Brazil/US were more obvious destinations for European emigrés. Villax built the business as a pharmaceutical API synthesizer, and the company remained family-controlled through his son and grandson (three generations of the Villax/Gandra family). What distinguishes Hovione from CDMOs that were sold to private equity is this decades-long family commitment to specialty pharmaceutical chemistry: Hovione invested heavily in spray drying and particle engineering for inhalation APIs in the 1980s-1990s — years before big pharma began outsourcing these capabilities — becoming one of the world's leading independent CDMOs in a niche that is now critical for asthma, COPD, and cancer drugs. A Czech chemist's Cold War escape to Portugal created one of the most technically differentiated pharmaceutical contract manufacturers in Europe.

  Hovione ↗

• Concentration2024

  The pharmaceutical amorphous solid dispersion (ASD) market — converting poorly water-soluble drug molecules to bioavailable amorphous form through spray drying — is concentrated in approximately 6-8 global CDMOs: Hovione, Lonza, Catalent, Bend Bioscience, Thermo Fisher, and a few others. Approximately 40-50% of new drug candidates in development pipelines have solubility problems that require ASD spray drying to achieve therapeutic plasma levels. As pharmaceutical companies advance more complex molecules with low aqueous solubility (driven by HTS drug discovery producing hydrophobic molecules), the fraction of new approvals requiring ASD manufacturing increases each cycle. Hovione's spray drying capacity — built across four facilities in Portugal, Macau, Ireland, and the US — is therefore embedded in the critical path for a large and growing share of new pharmaceutical approvals. A private family company in Portugal controls essential enabling capacity for a pharmaceutical innovation pipeline that serves hundreds of millions of patients.

  Hovione ↗